Business Description
![ORIC Pharmaceuticals Inc ORIC Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C0000BSC8.png?14)
ORIC Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US68622P1093
Description
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 114.15 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.03 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 1.1 | |||||
3-Year EPS without NRI Growth Rate | 4.2 | |||||
3-Year FCF Growth Rate | 7 | |||||
3-Year Book Growth Rate | -19.7 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.83 | |||||
9-Day RSI | 71.83 | |||||
14-Day RSI | 69.85 | |||||
6-1 Month Momentum % | -35.06 | |||||
12-1 Month Momentum % | -23.97 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 21.31 | |||||
Quick Ratio | 21.31 | |||||
Cash Ratio | 20.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.4 | |||||
Shareholder Yield % | -27.69 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -40.01 | |||||
ROA % | -36.46 | |||||
ROIC % | -286.88 | |||||
ROC (Joel Greenblatt) % | -3781.14 | |||||
ROCE % | -43.49 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.44 | |||||
Price-to-Tangible-Book | 2.44 | |||||
EV-to-EBIT | -3.89 | |||||
EV-to-EBITDA | -3.93 | |||||
EV-to-FCF | -4.62 | |||||
Price-to-Net-Current-Asset-Value | 2.66 | |||||
Price-to-Net-Cash | 2.72 | |||||
Earnings Yield (Greenblatt) % | -25.71 | |||||
FCF Yield % | -11.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ORIC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ORIC Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -1.81 | ||
Beta | 0.81 | ||
Volatility % | 68.39 | ||
14-Day RSI | 69.85 | ||
14-Day ATR ($) | 0.681327 | ||
20-Day SMA ($) | 9.408 | ||
12-1 Month Momentum % | -23.97 | ||
52-Week Range ($) | 5.27 - 16.65 | ||
Shares Outstanding (Mil) | 67.42 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ORIC Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ORIC Pharmaceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
ORIC Pharmaceuticals Inc Frequently Asked Questions
What is ORIC Pharmaceuticals Inc(ORIC)'s stock price today?
The current price of ORIC is $11.89. The 52 week high of ORIC is $16.65 and 52 week low is $5.27.
When is next earnings date of ORIC Pharmaceuticals Inc(ORIC)?
The next earnings date of ORIC Pharmaceuticals Inc(ORIC) is 2024-08-09 Est..
Does ORIC Pharmaceuticals Inc(ORIC) pay dividends? If so, how much?
ORIC Pharmaceuticals Inc(ORIC) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |